Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jamcollsurg.2020.11.032DOI Listing

Publication Analysis

Top Keywords

debunking myth
4
myth clothing
4
clothing electronic
4
electronic devices
4
devices surgical
4
surgical site
4
site infection
4
debunking
1
clothing
1
electronic
1

Similar Publications

The myth of a cancer-specific temperament: An analysis of affective temperament in cancer patients.

J Psychosom Res

December 2024

Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.

Objective: We investigate the prevalence of five affective temperaments (depressive, cyclothymic, hyperthymic, irritable, and anxious) in a large sample of cancer patients and associations of temperament with cancer site as well as the impact of temperament on overall survival of cancer patients.

Methods: Data for this prospective cohort study was collected in the outpatient clinic of a large cancer center. We used the Temperament Evaluation in Memphis, Pisa and San Diego - Münster Version (TEMPS-M) and recorded patient data.

View Article and Find Full Text PDF

Metronomic Chemotherapy in Breast Cancer as a Strategy to Deliver More Sustainable and Less Toxic Treatments: Time to Debunk the Myth?

Clin Breast Cancer

November 2024

Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. Electronic address:

Breast cancer is the most commonly diagnosed cancer in women, worldwide. With the increasing burden of breast cancer, the search for more tolerable and sustainable treatments is required, to result in broader access to cancer treatments. Metronomic chemotherapy defines the use of chemotherapy agents based on low-dose, continuous regimens, as opposed to traditional treatments administered for limited intervals, at higher dose.

View Article and Find Full Text PDF

The purpose of this study was to develop and validate a new measurement tool designed to capture endorsement of myths surrounding female perpetrated sexual violence against men, specifically in 'forced-to-penetrate' cases. Data were collected among a sample of 4152 UK adults aged 18-55+ (52% female). Dimensionality and construct validity of the Forced-to-Penetrate Myth Acceptance Scale (FTP-MAS) was investigated using traditional Confirmatory Factor Analysis (CFA) techniques separately for the complete sample, males only, and females only.

View Article and Find Full Text PDF

Debunking the Myth: Should Pierre Robin be Credited for Defining the Pierre Robin Sequence?

Otolaryngol Head Neck Surg

November 2024

Department of Pediatric Otolaryngology, AP-HP, Necker-Enfants Malades Hospital, Paris, France.

The Pierre Robin Sequence is a rare craniofacial malformation that invariably combines retrognathism, glossoptosis, and upper airway obstruction, with a prevalence ranging from 1 in 8000 to 1 in 14,000 newborns. Although formally described by the French physician Pierre Robin in 1923, older and even ancient as far back as the Babylonian times, descriptions have been identified. Dr Pierre Robin's perspicacity lay in putting up a treatment for the patients presenting those symptoms.

View Article and Find Full Text PDF

Most physicians appreciate that practicing medicine is a commitment to continuous learning. However, "learning" can be mistakenly understood as simply the acquisition of facts and new knowledge. But learning also necessitates the constant re-examination and challenging of one's existing body of knowledge, as misinformation persists when one's beliefs are not challenged or questioned in the light of new information.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!